Combined genetic assessment of transforming growth factor-β signaling pathway variants may predict breast cancer risk

Cancer Research

Volumn 65, Issue 8, 2005, Pages 3454-3461

  Kaklamani, Virginia G ^a   Baddi, Lisa ^a   Liu, Junjian ^a   Rosman, Diana ^a   Phukan, Sharbani ^a   Bradley, Ciarán ^a   Hegarty, Chris ^a   McDaniel, Bree ^a   Rademaker, Alfred ^a   Oddoux, Carole ^b   Ostrer, Harry ^b   Michel, Loren S ^c   Huang, Helen ^c   Chen, Yu ^d   Ahsan, Habibul ^d   Offit, Kenneth ^c   Pasche, Boris ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENETIC ANALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN VARIANT; SIGNAL TRANSDUCTION;

EID: 20244383746     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2961     Document Type: Article

References (41)

1. Arteaga CL, Dugger TC, Hurd SD. The multifunctional role of transforming growth factor (TGF)-β on mammary epithelial cell biology. Breast Cancer Res Treat 1996;38:49-56.
2. Reiss M, Barcelloshoff MH. Transforming growth factor-β in breast cancer - a working hypothesis [review]. Breast Cancer Res 1997;45:81-95.
3. Wakefield LM, Roberts AB. TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002;12:22-9.
4. Akhurst RJ, Derynck R. TGF-β signaling in cancer - a double-edged sword. Trends Cell Biol 2001;11:844-51.
5. Sporn MB, Roberts AB. TGF-β: problems and prospects. Cell Regul 1990;1:875-82.
6. Pierce DF Jr, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci U S A 1995;92:4254-8.
7. Cui W, Fowlis DJ, Bryson S, et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-42.
8. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J. Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci 2003;100:8430.
9. Syrris P, Carter ND, Metcalfe JC, et al. Transforming growth factor-β gene polymorphisms and coronary artery disease. Clin Sci 1998;95:659-67.
10. Dunning AM, Ellis PD, McBride S, et al. A transforming growth factor β1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003;63:2610-5.
11. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 1999;8:93-7.
12. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-β-1 gene in relation to myocardial infarction and blood pressure - the Etude Cas-Temoin de Linfarctus du Myocarde (ECTIM) Study. Hypertension 1996;28:881-7.
13. Holweg CT, Baan CC, Niesters HG, et al. TGF-β1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 2001;20:979-84.
14. Beranek M, Kankova K, Benes P, et al. Polymorphism R25P in the gene encoding transforming growth factor-β (TGF-β1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 2002;109:278-83.
15. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29 → C polymorphism in the transforming growth factor β1 gene and breast cancer among elderly white women: The study of osteoporotic fractures. JAMA 2001;285:2859-63.
16. Hishida A, Iwata H, Hamajima N, et al. Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer 2003;10:63-9.
17. Krippl P, Langsenlehner U, Renner W, et al. The L10P polymorphism of the transforming growth factor-β1 gene is not associated with breast cancer risk. Cancer Lett 2003;201:181-4.
18. Marchand LL, Haiman CA, van den Berg D, Wilkens LR, Kolonel LN, Henderson BE. T29C Polymorphism in the transforming growth factor β1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 2004;13:412-5.
19. Shu XO, Gao YT, Cai Q, et al. Genetic polymorphisms in the TGF-β1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 2004;64:836-9.
20. Suthanthiran M, Li BG, Song JO, et al. Transforming growth factor-β(1) hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc 2000;97:3479-84.
21. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-β-1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569-76.
22. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-7.
23. Pasche B, Luo Y, Rao PH, et al. Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 1998;58:2727-32.
24. Chen T, de Vries EG, Hollema H, et al. Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma. Int J Cancer 1999;82:43-51.
25. Pasche B, Kolachana P, Nafa K, et al. T β R-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999;59:5678-82.
26. Baxter SW, Choong DY, Eccles DM, Campbell IG. Transforming growth factor β receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2002;11:211-4.
27. Kaklamani VG, Hou N, Bian Y, et al. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol 2003;21:3236-43.
28. Pasche B, Kaklamani VG, Hou N, et al. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004;22:756-8.
29. Pasche B, Luo Y, Rao PH, et al. Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 1998;58:2727-32.
30. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-7.
31. Pasche B. Role of transforming growth factor β in cancer. J Cell Physiol 2001;186:153-68.
32. Bian Y, Kaklamani V, Reich J, Pasche B. TGF-β signaling alterations in cancer. Cancer Treat Res 2003;115:73-94.
33. Roberts AB, Wakefield LM. The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci 2003;100:8621.
34. Bandyopadhyay A, Zhu Y, Cibull ML, Bao LW, Chen CG, Sun LZ. A soluble transforming growth factor β type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Res 1999;59:5041-6.
35. Yin JJ, Selander K, Chirgwin JM, et al. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999;103:197-206.
36. Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 2002;109:1551-9.
37. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-β-1 and HA-ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996;10:2462-77.
38. Oft M, Heider KH, Beug H. TGF-β signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998;8:1243-52.
39. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000;101:2783-7.
40. Shu XO, Gao YT, Cai Q, et al. Genetic polymorphisms in the TGF-β1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 2004;64:836-9.
41. Akhurst RJ. TGF β signaling in health and disease. Nat Genet 2004;36:790-2.